Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market

Affiliations

¹ Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, philip.almeter@uky.edu Department of Anesthesiology, University of Kentucky College of Medicine, Lexington, Kentucky Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky Division of Pulmonary, Critical Care and Sleep Medicine, University of Kentucky College of Medicine, Lexington, Kentucky.

Comment

Philip J Almeter et al. Anesth Analg. 2019 Apr.

. 2019 Apr;128(4):e55-e56.

doi: 10.1213/ANE.0000000000004042.

¹ Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, philip.almeter@uky.edu Department of Anesthesiology, University of Kentucky College of Medicine, Lexington, Kentucky Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky Division of Pulmonary, Critical Care and Sleep Medicine, University of Kentucky College of Medicine, Lexington, Kentucky.

No abstract available

Comment on

US Food and Drug Administration Disruption of Generic Drug Market Increases Hospital Costs.
Almeter PJ, Labuhn JA, Morris PE, Hessel EA 2nd. Almeter PJ, et al. Anesth Analg. 2018 Dec;127(6):1414-1420. doi: 10.1213/ANE.0000000000003589. Anesth Analg. 2018. PMID: 29944521
Clarifying Misconceptions About US Food and Drug Administration Unapproved Drugs Program.
Ashley DD. Ashley DD. Anesth Analg. 2018 Dec;127(6):1292-1294. doi: 10.1213/ANE.0000000000003852. Anesth Analg. 2018. PMID: 30433920 No abstract available.